Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial adhesion to urothelial cells is a critical early event in the pathogenesis of urinary tract infections (UTIs). This process enables uropathogenic bacteria, most notably *Escherichia coli* (UPEC), to colonize and invade the urinary tract, leading to infection. The interaction involves specific bacterial surface structures called adhesins that recognize and bind to receptors on the surface of urothelial cells. Key bacterial adhesins include Type 1 fimbriae (FimH adhesin) which binds to uroplakins, and P pili (PapG adhesin).
Inhibition of bacterial adhesion to urothelial cells, competition for binding sites
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Adhesion to Urothelial Cells.